Enanta Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Enanta Pharmaceuticals Inc
TickerENTA
CIK #0001177648
CUSIP29251M106
SectorLife Sciences - Pharmaceutical Preparations
Address500 Arsenal Street, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2025
[0001177648] 10-K
[0001177648] 10-Q
[0001177648] 3
[0001177648] 4
[0001177648] 8-K
[0001177648] SC 13D
[0001177648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Enanta Pharmaceuticals Inc [2025-01-22] 0.0
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2024-02-27] 0.0
Millennium Management LLC Enanta Pharmaceuticals Inc [2024-01-11] 6.2
Millennium Management LLC Enanta Pharmaceuticals Inc [2023-11-16] 4.9
Armistice Capital LLC Enanta Pharmaceuticals Inc [2023-02-14] 0.99
BlackRock Inc Enanta Pharmaceuticals Inc [2023-01-31] 18.0
First Manhattan Co Enanta Pharmaceuticals Inc [2022-02-15] 5.46
Armistice Capital LLC Enanta Pharmaceuticals Inc [2021-02-16] 6.7
Renaissance Technologies LLC Enanta Pharmaceuticals Inc [2021-02-10] 5.13
State Street Corp Enanta Pharmaceuticals Inc [2021-02-09] 5.84
BlackRock Inc Enanta Pharmaceuticals Inc [2021-01-25] 17.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2019-09-27] 1.1
Price T Rowe Associates Inc /MD/ Enanta Pharmaceuticals Inc [2019-02-14] 5.5
Vanguard Group Inc Enanta Pharmaceuticals Inc [2019-02-11] 7.85
LULY Jay R Enanta Pharmaceuticals Inc [2019-01-18] 5.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2018-05-10] 1.1
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2017-02-15] 4.6
Apex Capital Management Enanta Pharmaceuticals Inc [2016-02-10] 5.0
BlackRock Inc Enanta Pharmaceuticals Inc [2016-01-28] 8.9
Consonance Capital Management LP Enanta Pharmaceuticals Inc [2015-02-17] 0.1
Eagle Asset Management Inc Enanta Pharmaceuticals Inc [2015-01-07] 5.96
Dworsky Alan J Enanta Pharmaceuticals Inc [2014-09-18] 5.4
RA Capital Management LLC Enanta Pharmaceuticals Inc [2014-04-01] 8.0
TVM V Life Science Ventures GmbH & Co KG Enanta Pharmaceuticals Inc [2014-02-14] 14.1
FMR LLC Enanta Pharmaceuticals Inc [2014-02-14] 0.0
MRNA - Holdings LLC Enanta Pharmaceuticals Inc [2014-02-13] 0.1
AbbVie Inc Enanta Pharmaceuticals Inc [2014-02-07] 5.97
Shionogi & Co Ltd Enanta Pharmaceuticals Inc [2014-01-29] 8.9
HBM Healthcare Investments Cayman Ltd Enanta Pharmaceuticals Inc [2013-04-03] 8.69
Form 3/4/5 Filer 2011 - 2025
Enanta Pharmaceuticals Inc
Rottinghaus Scott T.
Vance Terry
Carter Bruce L A
Peterson Kristine
Hata Yujiro S
Foletta Mark G
Russell Lesley
Mellett Paul J
Luu Brendan
Kieffer Tara Lynn
Or Yat Sun
Luly Jay R.
Kowalsky Matthew Paul
Gardiner Nathaniel S.
Adda Nathalie
Golumbeski George
Buckley Stephen Jr.
Ocain Tim
Afting Ernst-Guenter
TVM IV Management GmbH & Co. KG
TVM Capital GmbH
Birner Hubert
TVM IV GmbH & Co KG
TVM Medical Ventures GmbH & Co KG
Fischer Stefan
TVM V Life Science Ventures Management GmbH & Co. KG
TVM V Life Science Ventures GmbH & Co KG
Goll Alexandra
Schuhsler Helmut
Goldberg Marc E.
OBP (Bermuda) III - Holdings LLC
OBP III - Holdings LLC
Saints Capital Granite, LLC
Saints Capital Granite LP
OBP (Adjunct) III - Holdings LLC
mRNA - Holdings LLC
Shionogi & Co Ltd
Verdine Gregory L.
Poorvin David
Form 13F Holdings
Firm Period DFND Voting Shares
Farallon Capital Management LLC [2025-06-30] OTR 2,122,262 2,122,262
Krensavage Asset Management LLC [2025-06-30] SOLE 2,114,444 2,114,444
Vanguard Group Inc [2025-06-30] SOLE 0 1,953,197
BlackRock, Inc. [2025-06-30] SOLE 1,808,125 1,846,905
Millennium Management LLC [2025-06-30] SOLE 1,458,593 1,508,593
Marshall Wace LLP [2025-06-30] OTR 0 857,412
Stonepine Capital Management LLC [2025-06-30] SOLE 604,066 604,066
Janus Henderson Group PLC [2025-06-30] DFND 0 523,743
Geode Capital Management LLC [2025-06-30] DFND 485,797 485,797
State Street Corp [2025-06-30] DFND 438,366 470,270
Renaissance Technologies LLC [2025-06-30] SOLE 469,500 469,500
AQR Capital Management LLC [2025-06-30] DFND 376,283 384,975
Morgan Stanley [2025-06-30] DFND 278,952 286,526
D. E. Shaw & Co., Inc. [2025-06-30] DFND 273,647 282,276
Trexquant Investment LP [2025-06-30] SOLE 264,958 264,958
Dimensional Fund Advisors LP [2025-06-30] SOLE 235,991 259,819
Northern Trust Corp [2025-06-30] DFND 193,672 193,770
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 157,406 192,070
SIO Capital Management LLC [2025-06-30] SOLE 178,774 178,774
Charles Schwab Investment Management Inc [2025-06-30] SOLE 164,647 164,647
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 149,178 149,178
Two Sigma Advisers LP [2025-06-30] SOLE 124,800 133,600
JPMorgan Chase & Co [2025-06-30] DFND 106,840 130,433
Tang Capital Management LLC [2025-06-30] OTR 0 126,655
Goldman Sachs Group Inc [2025-06-30] DFND 115,235 116,135
Assenagon Asset Management S.A. [2025-06-30] SOLE 106,380 106,380
PDT Partners LLC [2025-06-30] SOLE 86,752 86,752
Qube Research & Technologies Ltd [2025-06-30] SOLE 83,912 83,912
Two Sigma Investments LP [2025-06-30] SOLE 78,455 78,455
SEI Investments Co [2025-06-30] SOLE 73,853 73,853
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com